GLPG1972

Galapagos' osteoarthritis drug flunks phase 2, dashing hopes of $250M Gilead deal
Fierce Biotech
Fri, 10/16/20 - 11:11 am
Galapagos
Servier
GLPG1972
osteoarthritis of the knee
clinical trials